標(biāo)題: Titlebook: Emerging Technologies for Diagnosing Alzheimer‘s Disease; Innovating with Care Marianne Boenink,Harro van Lente,Ellen Moors Book 2016 The E [打印本頁(yè)] 作者: ACE313 時(shí)間: 2025-3-21 18:12
書(shū)目名稱(chēng)Emerging Technologies for Diagnosing Alzheimer‘s Disease影響因子(影響力)
書(shū)目名稱(chēng)Emerging Technologies for Diagnosing Alzheimer‘s Disease影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Emerging Technologies for Diagnosing Alzheimer‘s Disease網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Emerging Technologies for Diagnosing Alzheimer‘s Disease網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Emerging Technologies for Diagnosing Alzheimer‘s Disease被引頻次
書(shū)目名稱(chēng)Emerging Technologies for Diagnosing Alzheimer‘s Disease被引頻次學(xué)科排名
書(shū)目名稱(chēng)Emerging Technologies for Diagnosing Alzheimer‘s Disease年度引用
書(shū)目名稱(chēng)Emerging Technologies for Diagnosing Alzheimer‘s Disease年度引用學(xué)科排名
書(shū)目名稱(chēng)Emerging Technologies for Diagnosing Alzheimer‘s Disease讀者反饋
書(shū)目名稱(chēng)Emerging Technologies for Diagnosing Alzheimer‘s Disease讀者反饋學(xué)科排名
作者: 使增至最大 時(shí)間: 2025-3-21 23:17 作者: 哥哥噴涌而出 時(shí)間: 2025-3-22 04:06
On Short Cuts: The Complexity of Studying the Early Diagnosis and Prevention of Alzheimer’s Diseasences in the conceptualization of the disease can be detected in this time period, especially the more recent trend towards prevention. While some preventive practices (such as brain training) and the search for early signs and biomarkers (such as APOEε4) have existed for a long time, the recent broa作者: 似少年 時(shí)間: 2025-3-22 07:56
Biomarkers for Alzheimer’s Disease: Searching for the Missing Link Between Biology and Clinicwhether research on molecular biomarkers for Alzheimer’s disease (AD) satisfies this criterion. To this end, she investigates how the interrelation of biological and clinical phenomena related to AD is conceptualized, pursued, and shaped in (1) discourse on biomarkers in general; (2) scientific lite作者: ATOPY 時(shí)間: 2025-3-22 10:49 作者: Precursor 時(shí)間: 2025-3-22 16:46 作者: Precursor 時(shí)間: 2025-3-22 19:49 作者: beta-carotene 時(shí)間: 2025-3-23 00:05
Testing Memory, Shifting Responsibility: Internet-Based (Self-) Diagnostics of Alzheimer’s Diseasetic tests for Alzheimer’s disease via the Internet affects the distribution of responsibility among relevant stakeholders. They provide counter-interpretations to these tests by considering the personal, social, and cultural background of the users inscribed in the design of the tests. They show tha作者: 情節(jié)劇 時(shí)間: 2025-3-23 02:26
Making Alzheimer’s Disease Matter: The Politics and Interferences of Different Practices Concerning ng AD are implicated in politics may help to make these politics more open, reflexive, and collective, and thus, contribute to responsible innovation. The chapter explores how Alzheimer’s disease is ‘made to matter’ in a number of locations, including an international Alzheimer’s patients’ movement;作者: Allege 時(shí)間: 2025-3-23 09:30 作者: Classify 時(shí)間: 2025-3-23 13:37
Responsible Innovation: The Case of Alzheimer Diagnosticsn with different concerned parties contributes to . innovation. Focusing on the case of Alzheimer diagnostics, Pols and M’charek demonstrate that innovations do not emerge in a linear way. Patient advocacy movements engage with scientific research, and research and clinical practices are highly inte作者: 貝雷帽 時(shí)間: 2025-3-23 15:05
Informally Regulated Innovation Systems: Challenges for Responsible Innovation in Diagnosticsbility study of personalized cancer care, the authors highlight the informally regulated nature of diagnostic innovation systems, where translational imperatives blur clinical and research aims, key regulatory institutions are bypassed, and other cognitive, normative, and regulative institutions enc作者: VOK 時(shí)間: 2025-3-23 21:31 作者: Mosaic 時(shí)間: 2025-3-23 23:07
Diagnosing Alzheimer’s Disease: How to Innovate with Careation exceeded the confines of memory clinics and research centres, but also included sites such as newspapers, policy documents, patient groups, general practitioners, and online diagnostics tools. The diversity of sites reflects the many faces and manifestations of AD: it is not just one thing but作者: 逢迎白雪 時(shí)間: 2025-3-24 02:36
Jonathan Gay,Yugo Nakamura,Erik Natzkechapter embraces the concept of responsible innovation. It concludes by calling for broader conceptions of bioethics and a new focus on community and public health approaches to late life cognitive and challenges.作者: 時(shí)代 時(shí)間: 2025-3-24 07:52 作者: Irksome 時(shí)間: 2025-3-24 11:39
https://doi.org/10.1007/978-3-031-13847-8es that patients’ and caregivers’ needs easily disappear from view while exploring the complex relations between biology and clinic, and suggests that to stimulate responsible AD biomarker research, both ‘epistemic’ and ‘translational’ responsibility need to be enhanced.作者: Solace 時(shí)間: 2025-3-24 16:06 作者: Prosaic 時(shí)間: 2025-3-24 21:00 作者: parallelism 時(shí)間: 2025-3-25 03:12
New Media in Black Women’s Autobiographymentia Commissioning for Quality and Innovation Framework (CQUIN), this tinkering work is constrained. The chapter concludes by reflecting on how the case of the CQUIN might inform the ways in which diagnostic innovation overall is dealt with responsibly.作者: maverick 時(shí)間: 2025-3-25 04:28
Shanthi Thambiah,Benjamin YH Lohtheir autonomy and privacy. Since the online availability of such diagnostics diminishes the accountability of developers and researchers, the chapter concludes with suggestions for improving the development of such tests, and for enhancing the Internet’s character as responsible innovation.作者: paroxysm 時(shí)間: 2025-3-25 10:57
Health, Wellness and Well-Being,and parliamentary politics. Moser argues that to open up the politics of AD, we need: first, to trace the multiplicity of realities-in-progress, the alternatives they present and the politics they imply; and, second, to appreciate the complex relations and interferences in which they are produced.作者: commensurate 時(shí)間: 2025-3-25 13:24
https://doi.org/10.1007/978-3-7091-0605-1different frames move in different directions. The process of constructing a national dementia strategy and the surrounding discussions take different shapes, depending on the assumed model of how approaches to dementia coexist.作者: 蟄伏 時(shí)間: 2025-3-25 19:06
Cationic Ring-Opening Polymerization, argue that responsible innovation, rather than privileging a particular type of laboratory research, should start innovations by taking notice of the different manifestations of ‘Alzheimer problems’ and the different science-clinic-representation practices needed to address these problems.作者: flex336 時(shí)間: 2025-3-25 22:44
Group transfer polymerizations,in on the current logic of valuing in HTA. It presents various empirical cases reporting on diagnostic innovations, and reflects on how HTA strategies, policies, and interventions for practitioners and users of diagnostic innovations could be more flexible and responsible.作者: Prosaic 時(shí)間: 2025-3-26 04:10
The Diagnosis and Treatment of Alzheimer’s: Are We Being (Ir)responsible?chapter embraces the concept of responsible innovation. It concludes by calling for broader conceptions of bioethics and a new focus on community and public health approaches to late life cognitive and challenges.作者: relieve 時(shí)間: 2025-3-26 07:11
On Short Cuts: The Complexity of Studying the Early Diagnosis and Prevention of Alzheimer’s Disease considerably impacted the conventional understanding of this syndrome and the possibilities for pharmacological and non-pharmacological interventions. A first reflection on ‘short cuts’ shows the difficulty of critically analysing the complex changes in the understanding of dementia.作者: 拉開(kāi)這車(chē)床 時(shí)間: 2025-3-26 09:17
Biomarkers for Alzheimer’s Disease: Searching for the Missing Link Between Biology and Clinices that patients’ and caregivers’ needs easily disappear from view while exploring the complex relations between biology and clinic, and suggests that to stimulate responsible AD biomarker research, both ‘epistemic’ and ‘translational’ responsibility need to be enhanced.作者: DRAFT 時(shí)間: 2025-3-26 14:27
Care and Responsibility in Building Futures for Alzheimer’s Disease Researchs for the ‘responsible’ development of research, and argue that the drive to combine and blend studies risks detaching research from these relations and the conditions in which they and data are co-produced.作者: 侵略者 時(shí)間: 2025-3-26 17:10 作者: Inclement 時(shí)間: 2025-3-26 23:08
Understanding Cognitive Screening Tools: Navigating Uncertainty in Everyday Clinical Practicementia Commissioning for Quality and Innovation Framework (CQUIN), this tinkering work is constrained. The chapter concludes by reflecting on how the case of the CQUIN might inform the ways in which diagnostic innovation overall is dealt with responsibly.作者: 令人不快 時(shí)間: 2025-3-27 02:49 作者: AUGER 時(shí)間: 2025-3-27 07:39 作者: 細(xì)胞學(xué) 時(shí)間: 2025-3-27 12:55 作者: 偏狂癥 時(shí)間: 2025-3-27 16:33 作者: deadlock 時(shí)間: 2025-3-27 21:20
Valuing Diagnostic Innovations: Towards Responsible Health Technology Assessmentin on the current logic of valuing in HTA. It presents various empirical cases reporting on diagnostic innovations, and reflects on how HTA strategies, policies, and interventions for practitioners and users of diagnostic innovations could be more flexible and responsible.作者: Override 時(shí)間: 2025-3-28 01:21 作者: 粘 時(shí)間: 2025-3-28 05:48
The Case Studies of Senior Appointments underlie Alzheimer’s disease. The usual claim is that these tests are more reliable, less burdensome, faster and/or cheaper than existing diagnostic procedures. But most importantly, the novel tests are thought to reveal Alzheimer’s at an early stage, possibly even years before the onset of symptoms.作者: 暫時(shí)中止 時(shí)間: 2025-3-28 08:19
,Emerging Technologies for Diagnosing Alzheimer’s Disease: Innovating with Care, underlie Alzheimer’s disease. The usual claim is that these tests are more reliable, less burdensome, faster and/or cheaper than existing diagnostic procedures. But most importantly, the novel tests are thought to reveal Alzheimer’s at an early stage, possibly even years before the onset of symptoms.作者: 同音 時(shí)間: 2025-3-28 10:32
https://doi.org/10.1007/b102415to produce diagnostic innovations of questionable value. Wider patient and public engagement, together with robust, legitimate, and accountable regulatory regimes will be required to truly ‘innovate with care’.作者: 處理 時(shí)間: 2025-3-28 15:39 作者: endure 時(shí)間: 2025-3-28 20:21
Informally Regulated Innovation Systems: Challenges for Responsible Innovation in Diagnosticsto produce diagnostic innovations of questionable value. Wider patient and public engagement, together with robust, legitimate, and accountable regulatory regimes will be required to truly ‘innovate with care’.作者: confide 時(shí)間: 2025-3-29 00:14 作者: 共同給與 時(shí)間: 2025-3-29 06:05
2946-3386 isciplinary reflections on the social and ethical issues raised by promises of early diagnostics and asks under which conditions emerging diagnostic technologies can be considered a responsible innovation.?.The initial chapters in this edited volume provide an overview and a critical discussion of r作者: 蒙太奇 時(shí)間: 2025-3-29 07:19
Health, Technology and Societyhttp://image.papertrans.cn/e/image/308412.jpg作者: 發(fā)生 時(shí)間: 2025-3-29 14:07
https://doi.org/10.1057/978-1-137-54097-3Medical Sociology; Health; Technology; Diagnosis; diagnostics; responsible innovation; biomarkers; technolo作者: 使長(zhǎng)胖 時(shí)間: 2025-3-29 19:22
The Editor(s) (if applicable) and The Author(s) 2016作者: MOT 時(shí)間: 2025-3-29 22:18
Emerging Technologies for Diagnosing Alzheimer‘s Disease978-1-137-54097-3Series ISSN 2946-3386 Series E-ISSN 2946-3378 作者: jettison 時(shí)間: 2025-3-30 02:55
The Case Studies of Senior Appointmentsb. The types of diagnostic tests recommended range from MRI and PET scans of the brain, to spinal taps, blood tests, simple eye cell tests, and even smelling peanut butter. Most of these tests measure so-called ‘biomarkers’: certain molecules in the body that are linked with the pathology thought to作者: 火車(chē)車(chē)輪 時(shí)間: 2025-3-30 04:58 作者: 潛伏期 時(shí)間: 2025-3-30 10:11
Tim Bird,Michael Cina,Michael Youngnces in the conceptualization of the disease can be detected in this time period, especially the more recent trend towards prevention. While some preventive practices (such as brain training) and the search for early signs and biomarkers (such as APOEε4) have existed for a long time, the recent broa作者: Encoding 時(shí)間: 2025-3-30 15:44
https://doi.org/10.1007/978-3-031-13847-8whether research on molecular biomarkers for Alzheimer’s disease (AD) satisfies this criterion. To this end, she investigates how the interrelation of biological and clinical phenomena related to AD is conceptualized, pursued, and shaped in (1) discourse on biomarkers in general; (2) scientific lite
